Patent US4304904A successfully refreshed from Google Patents.
US4304904A
Expired / Lapsed
US
⏱️ 0.0 years remaining
D-Erythro-2,3-dihydroxy-1-(and 3-) (1-phenyl-1H-pyrazolo[3,4,-b]quinoxalin-3-yl)propyl-β-D-glucopyranoside (and α-D-galactopyranoside) poly(H-sulfate) salts
Assignee: Wyeth Holdings LLC
•
Filing: 1980-03-03
•
Granted: 1981-12-08
•
Expires: 2000-03-03
Abstract
Abstract D-Erythro-2,3-dihydroxy-1-(and 3-) (1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl)propyl-β-D-glucopyranoside (and α-D-galactopyranoside) poly(H-sulfate)salts useful as complement inhibitors.
Inventors
- 👤 Vijay G. Nair
- 👤 Seymour Bernstein
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 08:09
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/26
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
31 words
A compound selected from those of the formulae: ##STR3## wherein X is -SO 3 R; wherein R is selected from the group consisting of hydrogen and a pharmaceutically acceptable salt cation.
Claim 2
Dependent Claim
31 words
A compound selected from those of the formulae: ##STR3## wherein X is -SO 3 R; wherein R is selected from the group consisting of hydrogen and a pharmaceutically acceptable salt cation.
Claim 3
Dependent Claim
12 words
The compound according to claim 1, D-erythro-2,3-dihydroxy-3-(1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl) propyl-α-D-galactopyranoside, hexakis(H-sulfate), hexasalt with trimethylamine.
Claim 4
Dependent Claim
11 words
The compound according to claim 1, D-erythro-2,3-dihydroxy-3-(1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl) propyl-α-D-galactopyranoside, hexakis(H-sulfate), hexasodium salt.
Claim 5
Dependent Claim
11 words
The compound according to claim 1, D-erythro-2,3-dihydroxy-1-(1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl)propyl-β-D-glucopyranoside, hexakis(H-sulfate), hexasalt with trimethylamine.
Claim 6
Dependent Claim
10 words
The compound according to claim 1, D-erythro-2,3-dihydroxy-1-(1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl)propyl-β-D-glucopyranoside, hexakis(H-sulfate), hexasodium salt.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-12-07 | 1985-06-08 | 1985-12-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-12-07 | 1989-06-08 | 1989-12-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-12-07 | 1993-06-08 | 1993-12-08 | $7700.00 | Window Closed / Lapsed |